| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/24/1992 | US5098714 Osmotic, oral dosage form for fertility control |
| 03/24/1992 | US5098711 Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| 03/24/1992 | US5098694 Glyceryl laurate, sorbic or benzoic acid, citric acid and aqueous/alcoholic carriers |
| 03/24/1992 | US5098691 A cobalamin compound such as vitamin B12 as the marking agent |
| 03/24/1992 | US5098621 Spreading a layer of micropackaged active material, mixing with surfactants and polyurethanes, molding and suspension |
| 03/24/1992 | US5098606 Lipids, sugars, water and nonionic surfactants for drugs |
| 03/24/1992 | US5098443 Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
| 03/24/1992 | US5098425 Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member |
| 03/24/1992 | US5098303 Dental tray with reservoir for holding sustained release solution of carboxypolymethylene (Carbopol") and urea peroxide |
| 03/24/1992 | CA1297791C Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| 03/24/1992 | CA1297754C Transdermal delivery device having a rate controlling adhesive |
| 03/24/1992 | CA1297725C Directly compressible powered maltitol and its process of preparation |
| 03/22/1992 | WO1992004889A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
| 03/22/1992 | CA2090231A1 Effective solid non-lozenge anti-acid/anti-gas medicament |
| 03/22/1992 | CA2030039A1 Sustained release morphine preparation for rectal administration |
| 03/21/1992 | WO1992004890A1 Sustained release compositions for treating periodontal disease |
| 03/21/1992 | CA2092087A1 Sustained release compositions for treating periodontol disease |
| 03/21/1992 | CA2051721A1 Nasal pharmaceutical composition |
| 03/20/1992 | CA2051748A1 Medicament and support |
| 03/19/1992 | WO1992004408A1 Shaped articles as obtained from a thermoplastic starch melt |
| 03/19/1992 | WO1992004037A1 Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic |
| 03/19/1992 | WO1992004035A1 Anti-inflammatory factor, method of isolation, and use |
| 03/19/1992 | WO1992004030A1 Stock solution of sucralfate suspended in water and production thereof |
| 03/19/1992 | WO1992004018A1 Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals |
| 03/19/1992 | WO1992004013A1 Multiparticulate sustained release matrix system |
| 03/19/1992 | WO1992004012A1 Antiemetic therapy |
| 03/19/1992 | WO1992004011A1 Dosage form for time-varying patterns of drug delivery |
| 03/19/1992 | WO1992004010A1 Stabilized liposome process and compositions containing them |
| 03/19/1992 | WO1992004009A1 Liposomes |
| 03/19/1992 | WO1992004008A1 Composition for treating ocular pain |
| 03/19/1992 | DE4038075C1 Encapsulating solid or liq. lipophilic agents - comprises mixing hydration medium with phospholipid increasing temp. to above soln. phase change temp. and adding remaining medium |
| 03/19/1992 | CA2073003A1 Composition for treating ocular pain |
| 03/18/1992 | EP0475894A1 Gemfibrozil formulations |
| 03/18/1992 | EP0475664A1 Lubricant composition and use thereof |
| 03/18/1992 | EP0475536A1 Spherical granules having core and their production |
| 03/18/1992 | EP0475482A1 Stabilized solid chemical compositions |
| 03/18/1992 | EP0475178A1 Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 03/18/1992 | EP0475160A1 Preparation for drug application in minute droplet form |
| 03/18/1992 | EP0474800A1 Eye-drop. |
| 03/18/1992 | EP0474714A1 A fructose-based granulated product and a process for the production thereof. |
| 03/18/1992 | EP0474647A1 Method and device for the release of drugs to the skin. |
| 03/18/1992 | EP0471036A4 Improved encapsulation process and products therefrom |
| 03/18/1992 | EP0461108A4 Partially fused peptide pellet |
| 03/18/1992 | EP0450080A4 Composition for the treatment of progressive myopia |
| 03/18/1992 | EP0380584B1 Polyene macrolide pre-liposomal powders |
| 03/18/1992 | EP0379500B1 Dermatological liposome composition containing pregnenolone |
| 03/18/1992 | EP0319545B1 Animal growth promotant |
| 03/18/1992 | EP0293465B1 Phospholipid composition |
| 03/18/1992 | EP0255827B1 Buccal formulation |
| 03/18/1992 | CN1059468A Ointments containing tricyclic compound |
| 03/18/1992 | CN1015873B Process for preparing exterior use liquid medicine for leukoderma |
| 03/18/1992 | CN1015871B Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-quinoling-3-carboxylic acid |
| 03/18/1992 | CA2050823A1 Fungicidal compositions and method |
| 03/17/1992 | US5096926 Injectable formulations containing the sodium salt of naproxen |
| 03/17/1992 | US5096916 Administering tolazoline |
| 03/17/1992 | US5096896 Pyrimethamine and injectable diluent which is the reaction product of acrolein tetramer and an alcohol or acid |
| 03/17/1992 | US5096891 Adenosine 3',5'-cyclic phosphate; dextrin, dextran and/or cyclodextrin; polymeric aluminum hydroxide gel, magnesium silicate and/or hydrotalcite; skin ulcers |
| 03/17/1992 | US5096885 Containing glycine, mannitol and a buffer; stabilization for freeze drying |
| 03/17/1992 | US5096717 Double-coated granules of disodium pamidronate |
| 03/17/1992 | US5096716 Dosage form for administering calcium antagonist nicardipine |
| 03/17/1992 | US5096715 Containing a fixed dosage, a vehicle and permeation enhancer |
| 03/17/1992 | US5096714 Prolonged release drug tablet formulations |
| 03/17/1992 | US5096697 Method of stimulating hair growth with aliphatic alcohols |
| 03/17/1992 | US5096629 Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes |
| 03/17/1992 | US5096492 Dispersed systems and method of manufacture |
| 03/17/1992 | US5095917 Contraceptives or antifertility agents |
| 03/17/1992 | CA1297627C Biologically degradable polymers for depot preparations havingcontrolled release of the active compound |
| 03/17/1992 | CA1297409C Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics |
| 03/17/1992 | CA1297408C Bioadhesive extruded film for intra-oral drug delivery and process |
| 03/17/1992 | CA1297407C Pharmaceutical which can be administered nasally, a process for it preparation, and its use |
| 03/17/1992 | CA1297370C Multi-layer delivery system |
| 03/17/1992 | CA1297369C Moisture activation of transdermal drug delivery system |
| 03/17/1992 | CA1297368C Pulsed drug delivery |
| 03/14/1992 | CA2025282A1 Process for preparing collagen-based composition product produced thereby, and method of applying same |
| 03/12/1992 | DE4028764A1 Prepn. of poly-D,L-lactide for use in implants |
| 03/12/1992 | DE4028622A1 Prepn. of collagen sponges for cosmetic and pharmaceutical use - by alkali treatment to denature surface, acid treatment, washing comminution, freezing and freeze drying |
| 03/11/1992 | WO1992004365A1 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| 03/11/1992 | EP0474453A2 Pharmaceutical composition comprising an active peptide or protein and a heat-labile enterotoxin B and its mucous use |
| 03/11/1992 | EP0474282A1 Use of polysaccharides in preparations for wound treatment |
| 03/11/1992 | EP0474126A1 Ointments containing tricyclic compound |
| 03/11/1992 | EP0474098A1 Controlled drug release composition |
| 03/11/1992 | EP0474040A1 Efferescent powder component and process for its production |
| 03/11/1992 | EP0473811A1 Ointment containing deprodone proprionate |
| 03/11/1992 | EP0473810A1 Water and deprodone proprionate -containing external preparations |
| 03/11/1992 | EP0473707A1 Injectable clarithromycin composition |
| 03/11/1992 | EP0473645A1 Insect repellant |
| 03/11/1992 | EP0455753A4 Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration |
| 03/11/1992 | EP0386000B1 Controlled release of antibiotic salts from an implant |
| 03/11/1992 | EP0169214B1 Anti-oestrogen drug for percutaneous administration |
| 03/11/1992 | CN1059346A Shaped apticles as obtained from thermoplastic starch melt |
| 03/11/1992 | CN1059279A Liposomes that provide thymic dependent help to weak vaccine antigens |
| 03/11/1992 | CN1059277A Local drug delivery compositions for dental use |
| 03/11/1992 | CN1059276A Pharmaceutical composition of florfenicol |
| 03/11/1992 | CA2050358A1 Lubricant composition and use thereof |
| 03/10/1992 | US5095151 Crystallization |
| 03/10/1992 | US5095097 Diagnostics |
| 03/10/1992 | US5095035 Sweet carrier |
| 03/10/1992 | US5095023 Niacin |
| 03/10/1992 | US5094854 Antitumor, hyperthermia |
| 03/10/1992 | US5094851 Corticosteroids |